D-1821-2019 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1821-2019 was initiated by American Health Packaging on Aug 9, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Nov 6, 2020). Affected quantity: 457 cartons.

Recall details

Product Type
Drugs
Report Date
Aug 21, 2019
Initiation Date
Aug 9, 2019
Termination Date
Nov 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
457 cartons

Product description

Carbamazepine, Extended-Release Tablets, USP, 400 mg, 30 Tablets (3 blister cards x 10 unit doses), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-562-21; NDC Unit Dose: 68084-562-11

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide USA

Code information

Lot 181677, exp 11/30/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1821-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1821-2019. Report a data issue: hello@regdatalab.com.